skip to Main Content

Videos

Watch our experts break down complex topics and suggest ways to adjust your business. Gain clarity, step-by-step.

Amelia Nell

Cell and Gene Therapy in Oncology, Part III

Tune into another episode of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, the final in our series on cell and gene therapies, experts from our Market Access practice discuss the need for patient support in cell and gene therapies, and the role that manufacturers and other stakeholders can play in providing it.

The Coverage Gap and Medicaid Expansion

Tune into another episode of Avalere Health Essential Voice. In this segment, our experts discuss the forthcoming debate around the coverage gap in non-Medicaid expansion states, potential policy options, and the impact on key stakeholders.

Megan West

Cell and Gene Therapy in Oncology, Part II

Tune into another episode of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, the second in a series focused on cell and gene therapies, experts from our Policy and Market Access practices discuss value-based payment arrangements in cell and gene therapies, and the role they play in facilitating access to these therapies.

Emily Belowich

Huntington’s Disease: Challenges and Treatment

Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, our experts from the Center for Healthcare Transformation discuss Huntington’s Disease, its impact on caregivers, the complexities of genetic testing, and potential treatment options for this rare disorder.

Lilian Buch

COVID-19 and Oncology Care

Tune into another episode in the Avalere Health Essential Voice series focused on disease education. In this segment, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the impact of COVID-19 on oncology care from a provider and patient perspective.

Oncology Care and NCCN Key Takeaways

Tune into another episode of the Avalere Health Essential Voice series focused on disease education. In this segment, our Market Access experts discuss major takeaways from the 2021 NCCN annual conference in the areas of diagnostics, holistic approaches to cancer treatment, and how the pandemic has influenced cancer care.

Christina Badaracco

Malnutrition and Quality Improvement

Tune into another episode of Avalere Health Essential Voice. In this segment of our Disease Education series, experts from our Center for Healthcare Transformation discuss the burden of malnutrition on our healthcare system and how an Avalere-led quality improvement initiative has helped systems across the country improve malnutrition identification and treatment.

Saran Traore

Patient Support Programs and Rare Disease

Tune into the second segment of the Avalere Health Essential Voice series focused on disease education. In this segment, experts from our Market Access practice discuss rare disease patient support programs and the need for stakeholder partnerships to address many of the barriers patients and their caregivers face.

Amy Schroeder

Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma

Tune into our first episode in the Avalere Health Essential Voice series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma.

Josh Seidman

What’s Next for Telehealth?

Tune into another episode of Start Your Day with Avalere. In this segment, our experts discuss the state of the telehealth sector, the issue of payment for virtual care, and the future of telehealth.

Social Determinants of Health: The Importance of Data, Part 2

Tune into the second segment of the Avalere Health Essential Voice podcast series focused on social determinants of health (SDOH) data. In this segment, Avalere experts discuss how life sciences organizations are beginning to recognize the importance and impact of this data, particularly in real-world evidence value demonstration work.

Christie Teigland

Social Determinants of Health: The Importance of Data, Part 1

In Part 1 of this segment focused on social determinants of health (SDOH), our experts from Avalere’s Health Economics and Advanced Analytics practice discuss the importance of SDOH data, how health plans are increasingly utilizing that data, and the ongoing limitations to data access.

Dan Mendelson

2020 Election with Avalere: COVID-19 Stakeholder Impacts

Tune into our seventh video of the Avalere Health Essential Voice: Election 2020 series. As election day approaches, our experts share their thoughts on how the COVID surge has changed the campaigns’ closing arguments, the current outlook on a COVID relief package, and how the election results will affect individual stakeholders.

Matt Kazan

2020 Election with Avalere: SCOTUS ACA Outlook

Tune into the fifth video of the Avalere Health Essential Voice: 2020 Election series. In this segment, our experts discuss the evolving makeup of the Supreme Court and the outlook on California vs. Texas — the upcoming Supreme Court case regarding the constitutionality of the Affordable Care Act and, in particular, the individual mandate. 

Sign up to receive more insights about Federal and State Policy
Please enter your email address to be notified when new Federal and State Policy insights are published.

Back To Top